Načítá se...
An In Vitro Microneutralization Assay for SARS‐CoV‐2 Serology and Drug Screening
The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) emerged in the city of Wuhan, Hubei Province, China, in late 2019. Since then, the virus has spread globally and caused a pandemic. Assays that can measure the antiviral activity of antibodies or antiviral compounds are needed for SARS...
Uloženo v:
| Vydáno v: | Curr Protoc Microbiol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7361222/ https://ncbi.nlm.nih.gov/pubmed/32585083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpmc.108 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|